WHO’s Sinopharm approval opens the door to distributing Chinese vaccines abroad
- In addition to dealing with spikes in India and Brazil, countries that border China should also receive priority for Chinese vaccines
- Being active in Covax and other multilateral channels can help overcome geopolitical hurdles and ensure access to more foreign markets in the future
Zha Daojiong is a professor at the School of International Studies, Peking University. His areas of expertise include the politics of China’s international economic relations, particularly the fields of energy and natural resources, development aid and the economics-political nexus in the Asia-Pacific region.